Position in LONA
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$842
+$222 QoQ
Shares Held
82
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LONA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026McIlrath & Eck, LLC holds $54,210 across 9 Biotechnology names. LONA ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
52 | $27,220 | |
| 2 | EXEL |
Exelixis, Inc.
|
454 | $19,472 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,000 | $3,400 | |
| 4 | XBIT |
XBiotech Inc.
|
753 | $1,769 | |
| 5 | MRNA |
Moderna, Inc.
|
25 | $1,270 | |
| 6 | LONA |
LeonaBio, Inc.
This page
|
82 | $842 | |
| 7 | NWBO |
Northwest Biotherapeutics Inc
|
600 | $126 | |
| 8 | TVRD |
Tvardi Therapeutics, Inc.
|
20 | $63 |
All Filings in LONA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $842 | 82 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $620 | 82 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $339 | 82 | Shares | Sole | 2025-10-22 | |
| No filing history on record for this holder in this stock. | ||||||